NeuroBo Pharmaceuticals I... (NRBO)
NASDAQ: NRBO
· Real-Time Price · USD
2.36
null (null%)
At close: Nov 27, 2024, 10:00 PM
NeuroBo Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -18.49M | -24.55M | -27.59M | -27.73M | -25.9M | -16.58M | -12.47M | -11.83M | -11.13M | -13.7M | -13.97M | -13.87M | -14.22M | -14.84M | -15.28M | -30.22M | -29.81M | -28.27M |
Depreciation & Amortization | 19K | 20K | 20K | 19K | 15K | 9K | 6K | 3K | 4K | 9K | 20K | 31K | 41K | 48K | 48K | 48K | 47K | 42K |
Stock-Based Compensation | 646.89K | 669.89K | 538K | 378.1K | 134.38K | 401.00 | -73.7K | -73.59K | -73.54K | 137.44K | 418.44K | 606.22K | 713K | 682K | 662K | 634K | 736K | 727K |
Other Working Capital | -1.2M | 1.19M | 22K | 3.04M | 3.99M | 3.48M | 4.24M | 1.7M | 2.23M | 344.4K | -1.37M | -880.6K | -888.6K | -632K | 578K | -1.43M | -226K | -1.01M |
Other Non-Cash Items | 1.54M | 876.11K | 1.08M | 2.71M | 369K | -2.84M | -1.69M | -430K | -579K | 2.5M | 2.42M | -43K | 20K | 25K | 24K | 17.36M | 17.37M | 17.37M |
Deferred Income Tax | n/a | n/a | n/a | -1.27M | -1.27M | -1.27M | -1.27M | n/a | 57K | 57K | 57K | 57K | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -2.62M | -92K | n/a | 1.88M | 5.24M | 4.44M | 4.4M | 2.71M | 2.5M | 1.06M | -1.17M | 121K | 416K | 258K | -584K | -2.41M | -2.38M | -2.63M |
Operating Cash Flow | -18.9M | -23.08M | -24.71M | -22.68M | -19.9M | -14.69M | -10.8M | -9.21M | -8.76M | -9.43M | -11.71M | -12.8M | -12.95M | -13.82M | -15.13M | -14.58M | -14.03M | -12.77M |
Capital Expenditures | -2K | -3K | -8K | -17K | -54K | -51K | -50K | -41K | -4K | -4K | n/a | 3K | 3K | n/a | n/a | -5K | -5K | -2K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 8K | 7.42K | 7.42K | -583 | -583 | 201K | 201K | 201K |
Purchase of Investments | 20M | 20M | 20M | 20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8K | 8K | 8.01K | 8.01K | -585.99K | -585.99K | -586K | -586K | -128K | -128K | -128K |
Investing Cash Flow | 20M | 20M | 19.99M | 19.98M | -54K | -51K | -50K | -33K | 4K | 12K | 16K | -575K | -575K | -586K | -586K | 68K | 68K | 71K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8.56M | 18.29M | 18.3M | 18.44M | 19.12M | -159.92K | -159.92K | -3.52M | -3.65M | -3.57M | -3.57M | -1.25M | -1.14M | -1.07M | -1.97M | -17.89M | -17.87M | -18.63M |
Financial Cash Flow | 8.56M | 18.29M | 18.3M | 18.52M | 19.2M | -80 | -80 | 28.73K | 28.6K | 28.68K | 28.68K | 12.89M | 12.86M | 12.93M | 22.03M | 9.14M | 9.16M | 15.9M |
Net Cash Flow | -10.35M | -4.8M | -6.42M | -4.17M | -754K | -14.82M | -10.93M | 19.48M | 19.84M | 19.26M | 16.98M | -628K | -664K | -1.48M | 6.3M | -5.37M | -4.79M | 3.22M |
Free Cash Flow | -18.91M | -23.09M | -24.72M | -22.69M | -19.95M | -14.74M | -10.85M | -9.25M | -8.76M | -9.43M | -11.71M | -12.8M | -12.95M | -13.82M | -15.13M | -14.59M | -14.04M | -12.77M |